Misplaced Pages

Paola Leone: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 11:37, 12 January 2024 editNivoc Alley (talk | contribs)323 editsNo edit summaryTags: Reverted Visual edit← Previous edit Revision as of 22:52, 7 March 2024 edit undoJustlettersandnumbers (talk | contribs)Autopatrolled, Administrators121,074 editsm sockpuppetry, please see Misplaced Pages:Sockpuppet investigations/BodiadubTag: RollbackNext edit →
Line 6: Line 6:
'''Paola Leone''' is an Italian researcher of ], a ]. '''Paola Leone''' is an Italian researcher of ], a ].


Leone was born and raised in ], ]. She received her undergraduate and graduate training in Italy, followed by post-doctoral studies in ] and ] in ]. She holds a doctorate degree in Neuroscience from the ].<ref>University of Medicine and Dentistry of New Jersey - {{Archive url|url=https://web.archive.org/web/20120219230514/http://som.umdnj.edu/research/cellbiology/faculty/leone.html|date=2012-02-19}}</ref> Her work on Canavan disease started at Yale, where she collaborated with other early pioneers in ]. She left Yale in 1998 to join the (now defunct) Cell & Gene Therapy Center at ] in ]. She directs The Cell & Gene Therapy Center at the ].<ref>University of Medicine and Dentistry of New Jersey - {{webarchive|url=https://archive.today/20090325090141/http://som.umdnj.edu/cgtweb/faculty/ |date=2009-03-25 }}.</ref><ref>{{Cite web|title=On the cusp of a cure for deadly childhood disease|url=https://today.rowan.edu/news/2020/11/on-the-cusp-of-a-cure-for-deadly-childhood-disease.html|access-date=2020-12-28|website=today.rowan.edu|language=en}}</ref><ref>{{Cite web|last=Ph.D|first=Miryam Z. Wahrman|title=Looking for cures|url=https://jewishstandard.timesofisrael.com/looking-for-cures/|access-date=2020-12-28|website=jewishstandard.timesofisrael.com|language=en-US}}</ref> Leone was born and raised in ], ]. She received her undergraduate and graduate training in Italy, followed by post-doctoral studies in ] and ] in ]. She holds a doctorate degree in Neuroscience from the ].<ref>University of Medicine and Dentistry of New Jersey - </ref> Her work on Canavan disease started at Yale, where she collaborated with other early pioneers in ]. She left Yale in 1998 to join the (now defunct) Cell & Gene Therapy Center at ] in ]. She directs The Cell & Gene Therapy Center at the ].<ref>University of Medicine and Dentistry of New Jersey - {{webarchive|url=https://archive.today/20090325090141/http://som.umdnj.edu/cgtweb/faculty/ |date=2009-03-25 }}.</ref><ref>{{Cite web|title=On the cusp of a cure for deadly childhood disease|url=https://today.rowan.edu/news/2020/11/on-the-cusp-of-a-cure-for-deadly-childhood-disease.html|access-date=2020-12-28|website=today.rowan.edu|language=en}}</ref><ref>{{Cite web|last=Ph.D|first=Miryam Z. Wahrman|title=Looking for cures|url=https://jewishstandard.timesofisrael.com/looking-for-cures/|access-date=2020-12-28|website=jewishstandard.timesofisrael.com|language=en-US}}</ref>


Recently,{{when?|date=November 2022}} she has been funded by ]-] and Jacob's Cure to study the potential of subpopulations of stem cells to promote remyelination and phenotypic rescue in animal models of white matter disease, including the Canavan mouse model. She is generating pre-clinical data using human Embryonic-Derived-Oligodendrocyte Stem Cells provided by ] (CA). These studies will provide a foundation for a targeted and comprehensive analysis of the potential of a cell-based therapy for ].<ref> {{Archive url|url=https://web.archive.org/web/20120304151216/http://jacobscure.org/canavan-research.php|date=2012-03-04}}</ref> Recently,{{when?|date=November 2022}} she has been funded by ]-] and Jacob's Cure to study the potential of subpopulations of stem cells to promote remyelination and phenotypic rescue in animal models of white matter disease, including the Canavan mouse model. She is generating pre-clinical data using human Embryonic-Derived-Oligodendrocyte Stem Cells provided by ] (CA). These studies will provide a foundation for a targeted and comprehensive analysis of the potential of a cell-based therapy for ].<ref></ref>


==References== ==References==

Revision as of 22:52, 7 March 2024

Italian biologist
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
The topic of this article may not meet Misplaced Pages's notability guideline for academics. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted.
Find sources: "Paola Leone" – news · newspapers · books · scholar · JSTOR (November 2022) (Learn how and when to remove this message)
This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help improve it by replacing them with more appropriate citations to reliable, independent, third-party sources. (November 2022) (Learn how and when to remove this message)
(Learn how and when to remove this message)

Paola Leone is an Italian researcher of Canavan disease, a leukodystrophy.

Leone was born and raised in Cagliari, Italy. She received her undergraduate and graduate training in Italy, followed by post-doctoral studies in Montreal and Yale University in New Haven, CT. She holds a doctorate degree in Neuroscience from the University of Padua. Her work on Canavan disease started at Yale, where she collaborated with other early pioneers in gene therapy. She left Yale in 1998 to join the (now defunct) Cell & Gene Therapy Center at Thomas Jefferson University in Philadelphia. She directs The Cell & Gene Therapy Center at the University of Medicine and Dentistry of New Jersey.

Recently, she has been funded by NIH-NINDS and Jacob's Cure to study the potential of subpopulations of stem cells to promote remyelination and phenotypic rescue in animal models of white matter disease, including the Canavan mouse model. She is generating pre-clinical data using human Embryonic-Derived-Oligodendrocyte Stem Cells provided by Geron Corporation (CA). These studies will provide a foundation for a targeted and comprehensive analysis of the potential of a cell-based therapy for Canavan Disease.

References

  1. University of Medicine and Dentistry of New Jersey - Faculty and Research Interests
  2. University of Medicine and Dentistry of New Jersey - Cell and Gene Therapy Center Faculty and Staff Archived 2009-03-25 at archive.today.
  3. "On the cusp of a cure for deadly childhood disease". today.rowan.edu. Retrieved 2020-12-28.
  4. Ph.D, Miryam Z. Wahrman. "Looking for cures". jewishstandard.timesofisrael.com. Retrieved 2020-12-28.
  5. Jacob's Cure Canavan Disease Research -


Stub icon

This biography related to medicine in Italy is a stub. You can help Misplaced Pages by expanding it.

Categories: